or merging with pfizer, depending how you feel. welcome back to "mad money." >> thanks for having me. >> have a seat. i have to tell you, tremendous respect for what you put together, mostly because you made a fortune for people. my first reaction was like i want brent and i want pfizer, brent gets me to 400, he has traced out an amazing vision for balance sheet gets better from the money or prop 7 acquisition of your own. why do i like this deal more than brent allergan? >> i think a great opportunity for our shareholders. the way i like to think about it, it is taking our growth far ma engine and putting it on a larger chassis called pfizer. look, we could have gotten into 400 on our own but this takes us well beyond that for the foreseeable future. and so the deep pipeline of pfizer, the combination of the global footprint and the strength in areas like immuno and vaccines makes this a powerhouse in biopharmaceuticals. >> your franchise, aesthetic, dermatological, gi, women's health, unassailable franchises. why would i get exci

pfizer in preliminary discussions with allergan, 115, $120 billion plus deal. thoughts?>> it's amazing what the "wall street journal" will do to fill a room. what can i say? no comment. we have an official position that we don't comment on speculation on potential m&a deals. >> if you don't mind. i'm not picking your pocket. >> we don't need this on anymore? >> no. without commenting on the specifics, you've been pretty vocal and pretty clear with your investors about what you feel about consolidation. what's your view, why should pfizer, obviously a big company already, what's the value in getting bigger from here? >> we've laid out i think in discussions with our investors that we have various future scenarios. one is to continue to look for organic growth. our in-line products are doing well. we have a number of really exciting new launches. that's why we had a really good quarter, with growth from emerging markets. so i always look at bd not only as a strategy but a way of facilitating strategies and accelerating, if possible, return to shareholders. we have a balanc

what does pfizer in 2020 look like? >> we've got a stated -- when i first came in i didn't talk about vision emission and later on we moved and we talked about purpose emission so our purpose is -- our submission to become the premier pharmaceutical company by the end of this decade and we described that as being highly respected, having people want to work for us, having life-saving medicines and being involved in conversations that the change or effect the juk which you are and outcome of the industry and having the right culture. i want people to want to come to pfizer. i want people to tell their families and friends this is a place to work. >> how do you change a culture of 80,000 employees? >> with a lot of effort and slowly and you need to get out and you need to talk. you would be amazed about how much work of a ceo and new management is about if you want to change culture is talking about it and then making sure that you act consistently. so we have something called own it, which is own in the business, win in

now, to pfizer and allergan.unced a $160 billion deal last week, that would be the biggest drug company. most of the deal allows on in version structure, allowing them to take advantage of lower tax rates in ireland. joining me now to discuss is beth seidenberg. you are also a doctor, you have founded multiple companies, been ceo of companies and then went into this. this is your wheelhouse. what do you make of this deal? beth: thank you for having me, great to see you. this is an interesting deal. there are economic drivers around the taxes and the ability to have a domicile in ireland. there are synergies with the portfolio. what is exciting is that this is a contrarian view. there are a lot of things that come out of a large merger. what we need with biotech, we need innovation. we need great people and we need product. and when you have an acquisition like this, there will be a few layoffs. the good news is with biotech, those are potential next-generation ceo's. those are people who can go into the growth st

pfizer. >> pfizer, we have liked it for a while. dan nathan of all people have been positive. >> of all people. >> he talks about it all the time. >> positive on something. >> positive. >> he is largely not a positive man. >> you know what? let's -- >> truth. >> he is very smart. >> very smart. >> there are two dan nathans? [ laughter ] >> go ahead. >> i think fiez sorry reasonable valuation. they have a lot in their pipeline. the stock was languishing at 33 bucks. this might be the catalyst to take it higher. >>> another wild day for go pro after the stock hit an all-time low. shares well 10% after morgan stanley downgraded the stock to underweight. slashed the price to 12 dollars siting inventory issues. i feel like every day there is another analyst on the street getting increasingly negative on this one. >> finally. where have they been, for crying out loud. this is a sthook is a hardware company. should it be valued like a hardware company. apple the trading ten times multiple of next year's earnings. this is trading at 14 time

xerox, pfizer and boeing were all higher after hours.ore than 1% while boeing is up more than 2%. guys back over to you. >> thanks for that. it was all about manning beckham's magic hands again in miami. both sides for fighting fir their playoff lights and beckham managed to help the giants with this catch in the third quarter. they lined up again in the fourth and went 84 yards on the play to secure the victory. manning threw for an 87.1% completion rate. a career high and a giant's record. i'm sure you were up into the late hours giving your monday night football picks. >> i always do. and many other things. >> and if you're just tuning in a reminder of your headlines. u. s. futures point to triple digit gains on the dow after the highest volume session in nearly three months. third avenue investigated, u.s. regulators open a probe into the junk bond blow up and a $14 billion buy back for boeing sent shares higher after hours. it's easy to buy insurance and forget about it. but the more you learn about your coverage, the more gaps you

pfizer had seen the field of gene editing. people were asking what's gene editing, what are you going to do with this and you are no leader if there is no forward and today you can feel the next wave things that are going to editing technology. >> i think you're absolutely right. it's highly speculative, only one patient, but what an amazing result. that's dr. andre shalicta he is the co-founder, chairman of cellectis, it is a french company but listed here, highly speculative, but, geez, if it works pretty big. stick with cramer. i asked my dentist if an electric toothbrush was going to clean better than a manual? he said sure. but don't get just any one. get one inspired by dentists. with a round brush head. go pro with oral-b. oral-b's rounded brush head cups your teeth to break up plaque and rotates to sweep it away. and oral-b delivers a clinically proven superior clean versus sonicare diamondclean. my mouth feels super clean. oral-b know you're getting a superior clean. i'm never going back to a manual brush. ugh! heartb

pfizer allergan. >> it is the biggest drug deal ever.value is almost on par with ireland's gdp. there's a lot of things to like with the steal. the biggest is the tax savings that pfizer is going to get. set up itsps pfizer established products business for a spin off. there are some question marks. there aren't as many operational synergies. overall this is a good deal. betty: anheuser-busch and sab miller. >> it's hard to say that this is a bad deal. it is beer and it is huge. anheuser-busch didn't have a lot of options and sab miller was the biggest most logical move. when you look at the combined company, it's not necessarily growing that fast. it is sort of a vicious cycle where you keep buying and you are not really growing that much. that's going to be a wait and see. betty: and finally shell bg group. >> this is a deal that makes a lot of sense strategically. it's just the timing that was a little rough. overly they had a very optimistic outlook on oil that they used to justify the price tag they are paying for bj. have comeoil p

pfizer had seen the field of gene editing. people were asking what's gene editing, what are you going to do with this and you are no leader if there is no forward and today you can feel the next wave things that are going to change 21st century in gene editing technology. >> i think you're absolutely right. it's highly speculative, only one patient, but what an amazing result. that's dr. andre shalicta he is the co-founder, chairman of cellectis, it is a french company but listed here, highly speculative, but, geez, if it works pretty big. stick with cramer. >>> all right. there's good and there's bad. nike and celgene good, nike is very strong some people are saying it's gone up too much, celgene has been weak for a long time we were worried about patent issues, a lot of them have been washed away by an agreement reached tonight and micron which i told you to stay away from because it's a commodity producer of chips delivers a commodity producer of chips number and gives you very little to hope for. we don't need commodity pl

we did this in front of pfizer executives in the city. they called us from italy, we came to rome to teach pfizer italy to do this. happy to do that. >> wow. >> they called us back, could you bring this, and pfizer will sponsor us in italy? children's hospital in rome -- >> wow. >> which i thought was really cool, an orthodox rabbi needed permission from the pope's office to teach an eastern meditative technique to vatican children. [laughter] it's so powerful. and now we're in ten hospitals in rome and 42 locations around the world. and the kids are teaching the world. >> rabbi g., your daughter's name, tell us her name. >> sarah. >> how old was she -- >> just past her second birthday. >> just past 2. >> and so i just recently wrote a book -- >> okay. >> the name of the book is "a perfect god created an imperfect world perfectly." and in there there are 30 life lessons teaching adults how to breathe in the light and push out stress. so the book is all about the children teaching the world, and if these kids who face down the most extraor

of pfizer.nd deness berman of "the wall street journal." -- dennis berman of "the wall street journal." dennis: well, good morning. ian: good morning. dennis: anything you'd like to tell us about? [laughter] ian: ok. tack your lead. dennis: pfizer in discussion th alogran, $150 billion-plus. thoughts. ian: it's amazing what "the wall street journal" will do to fill the room. no comment. we don't comment on peculation, on potential m&a deals. dennis: if you don't mind -- i am not picking your pocket. ian: we don't need this on anymore? dennis: no. not to comment but pretty vocal to your investors about consolidation. why should pfizer obviously a big company already, what's the value in getting bigger from here? ian: well, we've laid out, i think, in discussions to our investigation investors that we have various future scenarios. one is to continue to look for organic growth. our in-line products are doing well. we have a number of really exciting new launches. that's why we had a really good qu

the change will reduce pfizer's u-s tax liability to just 5-percent. clinton says as president she would close the loophole through executive order. the drug maker isn't clinton's only target... today in the metro she accused donald trump of helping isis... political director dave price has the story.. clinton has a comfortable lead not the case in new hampshire. a new c-n-n poll has vermont senator bernie sanders with 50-percent support. clinton is at 40-percent and martin o'malley is at one-percent. new hampshire holds the first in the nation primary on february ninth.. eight days after the iowa caucuses. donald trump is getting a lot of attention in west des moines... and this is the reason why... this large sign of donald trump is hard to miss along jordan creek parkway... the homeowner says he isn't for or against trump.. he just wants to get people thinking.. 18:14-18:39 what inspired me to put the sign up.... shaking up the establishment really well its also shaking up the internet... a photo of the dozens of comments from people trying to decid

becomes pfizer plc headquartered in dublin, 40,000 employees in the u.s.the united states. we won't avoid u.s. taxes. what we don't have to do is pay double tax on foreign earnings in the united states. maria: why should you. >> no one does, had he hoard the cash off shore and-- >> go ahead, dagen. >> if you get tax reform here and better taxation here, will you move back to the united states. maria: allergan is a u.s.-based company. dagen: if you get tax reform here, would you consider moving hq here? >> we will have to look at the top. >> it's a public company with public shareholders and he's got to do what's right for the public share shareholders. >> let me ask you, nine out of ten, history says nine out of ten mergers don't add value. as a ceo you've been one out of ten and you create a lot of value. part of doing deals is borrowing money at interest rates. the fed made this move yesterday and we talked about it. the you're a deal maker, does this have an impact on what can be done with the higher cost of capital? >> to be fair, it could. going up .2

anne: we are working on lupus with pfizer.e have a number of partnerships that we are doing with pharma companies. lupus and inflammatory bowel disease and parkinson's, we are about to launch a few others. emily: are you going to do human testing yourself here? anne: it will be asked best if -- it will react best if we come to them with a target or a compound with some clinical background. some data about how that is functioning. there is a higher likelihood of success if we can come with that level of information and move that forward. emily: you would do human testing here? anne: we would start doing some of our own clinical research for sure. emily: there is ancestry, they do some similar things. they have a partnership with calico. do you see google and calico as competition? anne: everything here is based on genetics and in gauging the consumer and making interesting, engaging products on them. calico is focused on anti-aging. i wish these companies well. i think it will expand the entire industry. i want to translate thi

personally, i was deeply distressed by the pfizer decision.w for instance, that drug companies spend more money on advertising than they do on research in our country. when they say, we will be able to spend more money on research, i would love to know the numbers. i find that hard to buy. there's a certain gamesmanship associated with it, that i find really regrettable. if we can beat the system, and ireland has a big welcome sign, we can go down as low as we can -- the rest of europe is annoyed. the united states is annoyed. i don't think inversions should be legal. i know the justice department and treasury department have looked at those. i don't think they should be. charlie: the president said it is unpatriotic. hillary clinton: they are, if you think about it. pfizer is a new york company. that is where its roots have been. as time went by, pfizer employed fewer people, but it has always been an american flagship company. them to say, oh, you know, this is really just a game -- if you listen to it, how many executives are actually going

now they just add the stuff to the bag of pfizer.does cost a fortune but pfizer has a worldwide sales force. powerful come bin nachlgs i am a believe. i wouldn't leavalerge al elerga tried. who is that? ♪ and then i followed her face >> it's ten seconds. >> sometimes the song is not there. >> people still love the mr. wolf thing. >> he can play "name ta tune" any day, by the way. >> on twitter i have been able to convince my kids because i'm remotely cool because i follow you. they say, dwlou know that? i keep my ear to the ground. i'm on carl's twitter feed. >> i thought the calls on lulu yet were interested. >> wasn't that interesting. >> and citi and credit suisse. >> they tell us not to worry. you know what? this is a true battleground. i'm going have to do some work on this. the lily was the stock that they bought it on the big dip. how fabulous is it that diabetes is on a decline? isn't that fabulous? >> it is on a major trend. >> they did attribute it to food, obvious. >> and diet and exercise. >> right. >> it gets back to the

pfizer. how big is pfizer? thousands of jobs will be lost.hey are also leaving because we have $2.5 trillion -- at least -- that is out of drink and -- out of the country these companies cannot get back because of bureaucracy and horrible agreements, but because the taxes are too high. they actually take the company, and move the company to the money. the republicans and democrats totally agree that the money should come back. for three years, they cannot get a deal. there is no leadership. it is gridlock. this is an example of something -- all the people appear, they all agree. they are politicians. all talk, no action. it is not like something where they can't agree. this is something that everybody agrees, the money should pour into this country, we should use this money. they agree, and they cannot get it done because of gridlock and incompetent leadership. >> hillary clinton, is she a friend of israel? mr. trump: honestly, i don't think anybody can say. she says she is, but all of a sudden, she says maybe less so than you thought because

>> karen and pfizer, what do you think? >> yeah. i'm going to go with pfizer in terms of valuation. it's the cheapest. and the offchance -- >> or maybe guy with an auto company now. why not go with ford? because you're steve grasso. sorry. >> all right. just two go into non sesecular. i don't think it's cheap here. you have a nice dividend. maybe have a bunch of cash, you could see a return to investors. >> i'm going to ge. >> nice to go straight up. >> i'm going to tell you. don't ever pick anything just for the dividend yield nap is the last thing you'll ever look for when you're looking at companies. but it is an important one. but it's the very last thing. when you look at ge, the reason i like this stock and i've been in this stock for some time now, is they have finally decided what they are. that is morphing themselves back into what they should be, an industrial company. they shed a lot of assets. and now they're clicking and i think in the next couple of years we'll see the kind of growth that nelson peltz sees out there. t

pfizer is leading the united states. in the old days would leave to south carolina, florida or someplace where the taxes are lower. today they leave this country for other countries. we are losing pfizer and losing our great companies. $2.5 trillion offshon and everybody agrees it should come home. for three years they can't make a deal. there is no leadership in washington. we will make this country so great. we have people -- and i'll tell you something -- i'll tell you something. somebody said something to me the other day and what i really want to do -- ] rowd jeering mr. trump: i want to be the people's president. think of this. i don't work for any of the lobbyists or any of these people that are leading our country in the wrong the best thing i've seen going around, and the thing of seen anything else, is how smart the people are. there don't believe those people in the back. colonel believe them.-- they don't believe them. the people are really smart. piration given me ins are the people of this country. we will

pfizer joining on board its other large cap cousins. pfizer shares focused on that dividend boost.nt to call your attention to what's happening with f 5 networks. the stock is moving marginally, however, they have announced a change in the c suite over at f 5 networks. they will be looking to replace -- they are going to replace their current ceo and what the company is saying, interestingly enough here is that john mcadam the crept care man of the carl pavano company is going to take over the president and ceo duties, he is to replace and succeed man we will rivelo who has resigned from his position for matters, quote, regarding personal conducted unrelated to the operations or financials of the company. so again, man we will rivelo who is currently the ceo and president of f 5 are stepping down for those undisclosed personal conduct issues that are not related to the company: john mcadam will take over that role of president and ceo, relinquish the chairman title so he can foes us on the executive duties. the board of directors say they will undertake a formal search process to i

and i'm going to give you pfizer. >> wow. >> which means health care is going to get obliterated tomorrow. >> i'm melissa lee. thanks for watching. see you tomorrow here at 5:00 for more "fast." meantime, "mad money" with jim cramer starts right now. >>> my mission is simple. to make you money. i'm here to level the playing field for all investors. there's always a bull market somewhere. i promise to help you find it. "mad money" starts now. hey i'm cramer. welcome to "mad money." welcome to cramerica. other people want to make friends and i'm trying to make you money. my job is to teach and coach you. call me at 1-800-743-cnbc or tweet me @jimcramer. why does the market seem so bad these days? what makes it seem lousy when the averages don't do good like today. nasdaq inched up .38%. some of it is because all we ever do is look at stocks through the prism of the federal reserve. every day we guessed what the fed will do and every day we make it harder and now that it's almost upon us this discussion monopolizes it. we know employment has been strong. there's no reason to keep short-term

soil.in@waterloo, hillary clinton promised to crack down on companies like pfizer, who have used loopholes to move assets overseas and avoid paying what she says is their fair share in taxes.she says she would ncourage congress to close the loopholes and instititute an exit tax to get earnings in the united states. and if congress won't act, then i will ask the tresury department when i'm there to use it's regulatory authohoty if that's what it takes. takes.clinton says that if congress won't do it, she believes she'd be able to do it through executive action. donald trump isn't backing down from his controversial proposal to ban all muslims from coming to the u-s.many have condemned the comments but that doesn't seem to be affecting his poll numbers. numbers.coming up toninit on the cbs 2 nene ten at ten.hear how america's oldest mosque, right here in the corridor, is fighting islamophobia. this season of giving, alliant energy today is working to make the season bright for the salvation army. army.bell ringing nats natsthe energy company tells cbs 2 news it will match up to one-thousand

a huge deal with pfizer. $160 billion is still spending.l have a couple of days of the year. we'll see what happen with that. >> landon, thank you so much. now 2015 i would say also the year for m&a activity in asia pacific topping a trillion which is a record amount for that region. up 37% for 2014 and the trend that i found the most surprising was the amount of money coming from japan. the japanese went shopping in a year when they hit 120 per u.s. dollar. they spent it mostly for u.s. assets. >> it's a great question. is japan back. is it business as it used to be? we saw the japanese get lost through a couple of decades as they tried to deal with what that excess leverage that was in the system. the debt workout. trying to get the mojo back after the nikkei fell so heavily here. >> a couple of interesting questions. are the japanese back and is this m&a in asia pacific going to continue at these levels because we know there's a little bit of pain in some of these economies as a result of what the dollar strength and the fed move on rate

the mother of all combinations is alagan and pfizer. which makes some politicians ann annoyed. they should be annoyed by addressing the tax code, which would take care of that. there were some big acquisitions. they bought, abbvie fellas bought that group, so more of that is going to happen. these are good size. we see that continuing to go. the close in 2016 would be anthem buying cigna. aetna, humana. we think those are more likely than not to close and make a big change in the health care delivery. >> sam, it's steve weiss. let's forget about the last three years when bio tech and health care led. but isn't this the relatively same environment you've been investing in health care basically for your entire career? now there are going to be winners and losers. basically, now you've really got to do your work. but the returns will still be there. for this sector. because it grows every year. is that fair? >> doing your work never changes. it is a treacherous area. you will have losers. there's no doubt. individual investors face a big challenge of picking individual stocks. we

anne: we are doing lupus with pfizer. a number of partnerships that we are doing with pharma companies. lupus and inflammatory bowel disease and parkinson's, we are about to launch a few others. emily: are you going to do human testing yourself here? anne: what we want to do and ,hat we want to do with pharma it will react best if we come to them with a target or a compound with some clinical background. some data about how that is functioning. there is a higher likelihood of success if we can come with that level of information and move that forward. emily: you would do human testing here? anne: we would start doing some of our own clinical research for sure. emily: there is some competition out there. ancestry.com does something similar. they have a partnership with calico. do you see google and calico as competition? anne: no. everything here is based on genetics and in gauging the consumer and making interesting, engaging products on them. calico is focused on anti-aging. i always wish all these companies well. i thin

pfizer. how big is pfizer? thousands of jobs will be lost. they are also leaving because we have $2.5 trillion -- at least that is out of drink and these companies cannot get back because of bureaucracy and horrible agreements, but because the taxes are too high. they actually take the company, and move the company to the money. the republicans and democrats totally agree that the money should come back. for three years, they cannot get a deal. there is no leadership. it is gridlock. this is an example of something -- all the people appear, they all agree. they are politicians. all talk, no action. it is not like something where .hey can't agree this is something that everybody agrees, the money should pour into this country, we should use this money. they agree, and they cannot get it done because of gridlock and incompetent leadership. >> hillary clinton, is she a friend of israel? honestly, i don't think anybody can say. she says she is, but all of a sudden, she says maybe less so than you thought because she is going far to the other side

. >> reporter: in a pair of megamergers, drugmakers pfizer and allergan announced plans to join forces. and dow chemical agreed to merge world. chipotle stock took a tumble to restaurant chain scrambled to contain a e. coli outbreak. mark zuckerberg and his wife welcomed a baby girl and they promised to donate the bulk of their $45 billion fortune to charity. a holiday gift to remember. jill wagner, cbs news, new york. > coming up after your local ws on "cbs this morning," an effort by food companies to swap out artificial ingredients in their food. we will have the details. plus, dr. david agus has his health predictions for 2016. and a look how the holiday shopping season is shaping up as we buy our last-minute presents. that is the "cbs morning news" for this thursday. thanks for watching. have a great day.> three people are dead following three different homicide investigations in the valley. where they happened.. and what one family is saying after two of their family members were killed. ((kirsten joyce)) > plus.. expect to go through a body scanner if you're heading to the airpo

pfizer. thousands of jobs for:but also to not trillion dollars at least that is added the country that companies cannot get back but the taxes are too high nobody would agree to pay that much so they moved the company to the money. >> for three years they cannot get the deal? it is a gridlock. but they cannot get it done because the politicians all top no action. everybody agrees the money should pour into the country. because of the incompetent leadership. >> every clinton? >> on a seattle think anyone can say she says she is now less because she is going to be riverside. >> look at what she says right now. whether she is or not she doesn't have the strength or the energy to help israel. i am telling you she does not. [applause] she does an event to those eager for another five days. think about it. she doesn't have the strength through the energy israel leaves more than support the new strength and power. because israel has difficulties these people are fighting dirty we used to think that

pfizer is the maker of viagra and allergan, the maker of botox, are going t tmerge. and soon people are going to be able to get the youngest-looking erection. [ laughter ] [ applause ] just, no wrinkles. many are speculating that peyton manning's career may be likely over after manning was benched in favor of quarterback brock osweiler. not only that, but papa john was spotted hanging out with cam newton. [ laughter ] i also have no on-screen chemistry. [ laughter ] miley cyrus last week performed in chicago while wearing a purple wig, mo boots, prosthetic breasts, and a large dildo. or as she calls it, casual friday. [ laughter ] a new ststy has found that specially-trained pigeons can have up to an 85% accuracy rate of detecting breast cancer in humans, which means that 15% of the time, it's just a pigeon staring atour boobs. [ laughter ] hoo. [ laughter ] hoo! [ laughter ] pretty good pigeon, you guys. a 14-year-old from k ktucky set a new record this weekenenafter solving a rubik's cube in just 4.9 seconds. though in kentucky, solving a it with a baseball bat. [

pfizer is leaving the united states. in the old days, someone would leave for south carolina or florida or someplace where the taxes are lower. they would leave for north carolina. today they leave this country for other countries, so we are now losing pfizer. we lose many of our great companies. $2.5 trillion all sure, at least. everyone believes they should come home, democrats and republicans. for three years they can't make a go because there's such gridlock. there is no leadership in washington. sowill make this country great. we have people -- and i will know,ou something, you somebody said something to me the other day and what i really want to do, i want to be -- it's all right. don't worry. forget it. what we want to do and what i want to do, i want to be the people's president. think of this. i don't work for any of the lobbyists. i don't work for any of these people that are leading our country in the wrong direction. thank you. [cheers and applause] mr. trump: the best thing i've seen going around and nothing

slowing, however, tim collins on and off the chart segment said you ought to take a hard look at pfizer because the stock was tracing out a reverse head and shoulders company. they would be the kind of company that i would shouldn't, i would normally never touch this thing when the economy is speeding up but if you take a look at this chart you can see pfizer traced out a left shoulder as it rallied through the month of october and then started declining aggressively, okay, in november, the stock bottomed to form the head and in december it caught a rally and a shoulder. the key with this pattern is the neckline, the line that connects the head to the two shoulders. when a stock breaks out above that line it tells the technician you are about to witness a big move. the neckline was at $25.80 and collins predicted it could be in for a month officer run. given that money was pouring out of the staples and drug stocks headed for the industrials i was reverse head and shoulders pattern. i didn't trust it one bit. come on, i'm a king of rotations i knew it was a bad stock but collins said ro

pfizer is up. but this group is down 14% versus the dow down 3.5 and the yield is double that of the daw. so a long-term chart since the early 1990s. if you rinse and repeat year after year, you tripled the performance of the dow jones itself and ten out of the last 15 years it has been prosperous. and so looking at proctor, and it has lagged the dow. here is the spread over three years. and year-to-date it is down 14. and to my eye, what we have here is a well-defined trend and a break from trend. you could also look at this kind of thing. head and shoulders bottom. but either way you cut it, i think this is a good place to put some money if you want to play dawgs of the dow theory. the other stock not discussed here is verizon. >> which you like. >> i do. if i had to pick two. >> who likes carter's dogs? >> i like the dividend. and there are catalysts in terms of brand spinoffs and this is part of the story. they are divesting noncore brands and i think it will be upside and the brand where the b

the biggest announcement was pfizer and allergan hooking up. this is ending.$160 billion merger. will the megamerger boom continue through the new year? how do you capitalize on it as an investor? mezereau investors, joining me the company's investment banking senior advisor. bill, it is just a busy year you just had. is your head spinning? >> i think all of our heads are spinning, liz. it's been a -- i think we're all in deal fatigue at this point. liz: why was it so hot this year and do you foresee it being at least as hot or warm next year? >> liz, the reasons that the market was so good this year are several. one, we had abu comic financing environment. debt financing available on historically attractive rates. accommodating equity market which reacted postively to many if not all deals which involved equity. and finally, very, very ample private equity funds available for financing. the environment broadly speaking. the tepid economy has led to a lot of activity. companies have been starved for growth at the top line, liz. with the result they have to do

and she wrote out new plans to stop companies like pfizer for merging with other overseas companies to avoid paying taxes. >> you should pay what you oh, just like everybody else. corporations don't need tax breaks, you need tax breaks. cynthia: after seeing her, many told her they will vote for her. >> seeing her in person is very convincing. she has got passion and fire. >> tonight seals the deal. she, to me, is the only person running that really has the knowledge and experience and the heart to run this country. cynthia: she spent 45 minutes answering questions, not one on isis, but social security, the v.a., and her stand on elizabeth: polls show her with a strong lead here in iowa, but a new hampshire a new cnn poll shows that bernie sanders has 50% support, ahead of clinton's 40%. >> i have always been a prankster ever since i was little. eric: have you seen this? it is the most talked about sign in the suburbs these days, as many drivers along jordan creek parkway are wondering who is behind it and what is the message. as mark tauscheck learned, it's not an easy answer. >> than

. >>> abc news "nightline," brought to you by pfizer. ry ellen, and i quit smoking with chantix. i have smoked for thirty years and by taking chantix, i was able to quit in three months. and that was amazing. along with support, chantix (varenicline) is proven to help people quit smoking. it absolutely reduced my urge to smoke. some people had changes in behavior, thinking or mood, hostility, agitation, depressed mood and suicidal thoughts or actions while taking or after stopping chantix. some had seizures while taking chantix. if you have any of these, stop chantix and call your doctor right away. tell your doctor about any history of mental health problems, which could get worse if you've had a serious allergic or skin reaction to it. if you have these, stop chantix and call your doctor right away as some can be life-threatening. tell your doctor if you have heart or blood vessel problems, or develop new or worse symptoms. get medical help right away if you have symptoms of a heart attack or stroke. decrease alcohol use while taking chantix. use caution when driving or operati

soil.in waterloo today , hillary clinton promised to crack down on companies like pfizer, that have used loopholes to move assets overseas and avoid paying what she says is their fair share in taxes.she says she would encourage congress to instititute an exit tax to get companies to keep their earnings in the u.s.clinton says if congress won't act, she will through executive action. media-com services should now the corridor.the cable and internet provider tells cbs 2 news, construction crews cut a fiber optic line near edgewood road at about one-30 this afternoon.that mistake cut cable and internet for customers in cedar rapids, coralville and iowa city. the company says it restored service to most costumers just about 30 minutes ago.all customers should be back online by midnight. now ten at ten continues with a look at tonight's other stories across the corridor. the cedar rapids public library is trying to decide how to use its resources after a levy vote for funding failed in november.a national group asking for strategic information from the library came just at the right time.50 c